![[img]](https://epub.uni-regensburg.de/style/images/fileicons/application_pdf.png) | Lizenz: Creative Commons Namensnennung 4.0 International PDF - Veröffentlichte Version (620kB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-530879
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.53087
Zusammenfassung
Background: Adoptive therapy with genetically modified T cells achieves spectacular remissions in advanced hematologic malignancies. In contrast to conventional drugs, this kind of therapy applies viable autologous T cells that are ex vivo genetically engineered with a chimeric antigen receptor (CAR) and are classified as advanced therapy medicinal products. Summary: As “living drugs,” CAR T ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
Downloadstatistik